Insiders · Profile

Piper Brian

Chief Financial Officer at Prelude Therapeutics. Filing since 25 May 2021. CIK 0001665924

Company
Date
Role
Action
Shares
Amount
Of holding
25 Aug 2021
Chief Financial Officer
Sold, plan not stated
8,333
$277.83K
100%
25 May 2021
Chief Financial Officer
Sold, plan not stated
8,333
$285.54K
100%
2 decisions on file.